I saw somewhere that said something if/when they finish clinicals, proving htlv-1 to cure aids or that 95%+ effective they would be very interested. I do not remember if the words or if commit was used.
Basically the news article was showing they had already talked. Could have been a year or two. Would have to research.
I think much more than gilead would be interested for a deal when the clinicals and fda approval happen here for not just hltv-1 and covid, but many other monoclonal antibodies.